The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells

Oncol Rep. 2023 Apr;49(4):75. doi: 10.3892/or.2023.8512. Epub 2023 Mar 3.

Abstract

In melanoma and other cancers, invasion, epithelial-to-mesenchymal transition, metastasis and cancer stem cell maintenance are regulated by transcription factors including the Snail family. Slug (Snail2) protein generally supports migration and apoptosis resistance. However, its role in melanoma is not completely understood. The present study investigated the transcriptional regulation of the SLUG gene in melanoma. It demonstrated that SLUG is under the control of the Hedgehog/GLI signaling pathway and is activated predominantly by the transcription factor GLI2. The SLUG gene promoter contains a high number of GLI-binding sites. Slug expression is activated by GLI factors in reporter assays and inhibited by GANT61 (GLI inhibitor) and cyclopamine (SMO inhibitor). SLUG mRNA levels are lowered by GANT61 as assessed by reverse transcription-quantitative PCR. Chromatin immunoprecipitation revealed abundant binding of factors GLI1-3 in the four subregions of the proximal SLUG promoter. Notably, melanoma-associated transcription factor (MITF) is an imperfect activator of the SLUG promoter in reporter assays, and downregulation of MITF had no effect on endogenous Slug protein levels. Immunohistochemical analysis confirmed the above findings and showed MITF-negative regions in metastatic melanoma that were positive for GLI2 and Slug. Taken together, the results demonstrated a previously unrecognized transcriptional activation mechanism of the SLUG gene, which may represent its main regulation of expression in melanoma cells.

Keywords: GLI family zinc finger; Hedgehog signaling; Slug; melanoma; melanoma-associated transcription factor.

MeSH terms

  • Apoptosis
  • Hedgehog Proteins* / genetics
  • Humans
  • Melanoma* / genetics
  • Signal Transduction
  • Transcription Factors / genetics

Substances

  • Hedgehog Proteins
  • Transcription Factors

Grants and funding

The present study was supported by funding from the institutional programs PROGRESQ25 and Cooperatio (research areas SURG, MED BIOCHEM, METABOLISM, and ONCOLOGY) from Charles University Prague, from the League against Cancer Prague, and from the Conceptual Development of Research Organization, Motol University Hospital, Prague, funded by the Ministry of Health, Czech Republic (grant no. 6028). These funding organizations played no role in the analysis of the data or the preparation of this article.